Or Metastatic Melanoma That Has Not Been Previously Treated with Selective Braf Inhibitor
📧 Sign up to get email alerts when something new happens for Or Metastatic Melanoma That Has Not Been Previously Treated with Selective Braf Inhibitor.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-05-28Clinical Trial Update: A Phase 1b Open Label, Dose Escalation Study of PLX3397 in Combination With Vemurafenib in V600-mutated BRAF Melanoma [Phase 1]
A Phase 1b open-label dose-escalation study of PLX3397 in combination with vemurafenib in V600-mutated BRAF melanoma has been terminated; re…